Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Netherlands Utrecht to prohibit the opening of new tobacconists…
  • Indonesia Specific regulations for e-cigs could cover heated tobacco…
  • Turkmenistan Fight against illegal import and sale of tobacco products to increase…
  • Russia Mandatory state licensing of production and circulation on the way…
  • Canada Date set for new rules on health warnings…
  • Ukraine Duty Free tobacco sales could be stopped…
  • Lithuania Health committee approves heated tobacco flavours ban…
  • India Tobacco warnings rule could force streaming services to quit India…
  • Malaysia Birthdate-based tobacco ban back on Parliament agenda…
  • Finland Retailers urged not to sell nicotine pouches pending new regulations…
  • Czech Republic Heated tobacco flavour ban signed into law…
  • South Africa Committee shows mixed reactions to tobacco control bill…
View all
News analysis

FDA rejects snus as modified risk – but could reconsider some aspects

Written by || 14th December 2016 || News analysis | Snus | North America United States

Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Court of Justice rejects Swedish Match bid to overturn European snus ban
FDA approves its first modified risk tobacco order for eight snus products
How Swedish Match snus finally got its FDA modified risk approval
© 2023
TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence,
does not accept any liability or responsibility for information or views published.